HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katsuro Tachibana Selected Research

azaspirene

5/2015Azaspirene analogs inhibit the growth of human uterine carcinosarcoma in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katsuro Tachibana Research Topics

Disease

24Neoplasms (Cancer)
01/2018 - 05/2002
5Lymphoma (Lymphomas)
01/2018 - 02/2003
5Melanoma (Melanoma, Malignant)
06/2012 - 08/2007
3Inflammation (Inflammations)
01/2020 - 03/2002
3Squamous Cell Carcinoma of Head and Neck
04/2018 - 01/2016
3Hyperthermia
07/2017 - 06/2009
2Mouth Neoplasms (Oral Cancer)
04/2018 - 01/2016
2Hematologic Neoplasms (Hematological Malignancy)
07/2017 - 12/2016
2Carcinosarcoma
09/2015 - 05/2015
2Sarcoma (Soft Tissue Sarcoma)
02/2011 - 06/2007
2Arterial Occlusive Diseases (Arterial Occlusive Disease)
11/2009 - 08/2008
2Stroke (Strokes)
08/2008 - 03/2004
2Carcinoma (Carcinomatosis)
11/2005 - 05/2002
1Nervous System Diseases (Neurological Disorders)
01/2024
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020
1Acute Liver Failure (Fulminant Hepatic Failure)
01/2020
1Necrosis
04/2018
1Rupture
01/2016
1Body Weight (Weight, Body)
09/2015
1Neoplasm Metastasis (Metastasis)
06/2012
1Osteosarcoma (Osteogenic Sarcoma)
08/2011
1Infections
01/2011
1Muscle Hypotonia (Hypotonia)
01/2010
1Hemorrhage
11/2009
1Diabetic Retinopathy (Retinopathy, Diabetic)
11/2009
1Thrombosis (Thrombus)
11/2009
1Vascular Diseases (Vascular Disease)
11/2009
1Neurofibroma
03/2009
1Atherosclerosis
08/2008
1Leukemia
02/2007
1Hepatocellular Carcinoma (Hepatoma)
11/2005
1Liver Neoplasms (Liver Cancer)
11/2005
1Hyperplasia
04/2004
1Myocardial Infarction
03/2004
1Drug-Related Side Effects and Adverse Reactions
12/2002
1Shock
12/2002

Drug/Important Bio-Agent (IBA)

4Contrast MediaIBA
12/2016 - 02/2003
4Liposomes (Liposome)IBA
06/2012 - 10/2006
3AlbuminsIBA
01/2024 - 01/2018
3Doxorubicin (Adriamycin)FDA LinkGeneric
04/2018 - 06/2009
3SuspensionsIBA
01/2016 - 02/2003
3titanium dioxide (Titania)FDA Link
01/2016 - 01/2011
3FS 069 (Optison)FDA Link
04/2004 - 03/2002
2Bortezomib (Velcade)FDA Link
07/2017 - 12/2016
2Peptides (Polypeptides)IBA
06/2012 - 02/2009
2AntigensIBA
06/2012 - 02/2009
2InterferonsIBA
07/2011 - 03/2009
2Fibrinolytic Agents (Antithrombotic Agents)IBA
08/2008 - 03/2004
2DNA (Deoxyribonucleic Acid)IBA
02/2007 - 03/2002
1SolutionsIBA
01/2024
1LuciferasesIBA
01/2020
1LipidsIBA
01/2020
1ThrombomodulinIBA
01/2020
1Tannic AcidFDA Link
04/2018
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
04/2018
1ResveratrolIBA
04/2018
1PolyphenolsIBA
04/2018
1Cetuximab (Erbitux)FDA Link
01/2018
1SonazoidIBA
12/2016
1Proteasome InhibitorsIBA
12/2016
14-chlorophenyl methyl sulfide (CPMS)IBA
09/2015
1calcium phosphateIBA
09/2015
1azaspireneIBA
05/2015
1Histocompatibility Antigens Class IIBA
06/2012
1Melphalan (Alkeran)FDA LinkGeneric
09/2011
1AK 2123IBA
04/2011
1Biomarkers (Surrogate Marker)IBA
02/2011
1Irinotecan (Camptosar)FDA LinkGeneric
02/2011
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2011
1Anti-Bacterial Agents (Antibiotics)IBA
01/2011
1FibrinIBA
11/2009
1Retinaldehyde (Retinal)IBA
11/2009
1Interferon-gamma (Interferon, gamma)IBA
03/2009
1perflutren (octafluoropropane)FDA Link
02/2009
1Bleomycin (Blenoxane)FDA LinkGeneric
08/2007
1Angiogenesis InhibitorsIBA
06/2007
1O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA
06/2007
1Proteins (Proteins, Gene)FDA Link
03/2006
1Trypan BlueFDA Link
03/2006
1Coloring Agents (Dyes)IBA
03/2006
1Complementary DNA (cDNA)IBA
03/2006
1Messenger RNA (mRNA)IBA
03/2006
1Green Fluorescent ProteinsIBA
11/2005
1OligodeoxyribonucleotidesIBA
04/2004
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
03/2004
1SHU 508 (Levovist)IBA
02/2003
1Antineoplastic Agents (Antineoplastics)IBA
12/2002
1GalliumIBA
05/2002
1Photosensitizing Agents (Photosensitizers)IBA
05/2002
1Carcinoembryonic AntigenIBA
05/2002
1PorphyrinsIBA
05/2002

Therapy/Procedure

16Therapeutics
01/2018 - 05/2002
10Microbubbles
01/2018 - 03/2004
4Drug Therapy (Chemotherapy)
05/2015 - 02/2011
3Radiotherapy
09/2015 - 06/2007
2Immunotherapy
06/2012 - 02/2009
1Microspheres (Microsphere)
09/2015
1Solid-State Lasers
11/2009
1Catheters
03/2004
1Intravenous Administration
05/2002